Carsten Schau Andersen

Title: Carsten Schau Andersen: Pioneering Innovator in the World of Enzyme Variants

Introduction: Carsten Schau Andersen, a visionary inventor hailing from Valby, DK, has made waves in the industry with his relentless pursuit of innovation. With an impressive 135 patents to his name, Andersen is a true trailblazer in pushing the boundaries of what is possible in the realm of inventions.

Latest Patents: Among his recent patents, Andersen has delved into the world of enzyme variants with inventions such as "Enzyme variants and polynucleotides encoding the same." This groundbreaking patent focuses on polypeptides with alpha-amylase activity, along with related polynucleotides, vectors, host cells, and methods. Another notable invention is the "Method for screening alpha-amylases," which explores variants of a parent alpha-amylase and their encoding polynucleotides.

Career Highlights: Andersen's impressive career spans across renowned companies such as Novozymes A/S and Novo Nordisk A/S. His impactful work in these organizations has helped shape the industry and solidify his reputation as a leading innovator in the field of enzyme variants and beyond.

Collaborations: Throughout his career, Carsten Schau Andersen has collaborated with esteemed coworkers such as Allan Svendsen and Signe Eskildsen Larsen. Together, they have worked tirelessly to bring forth novel inventions and drive technological advancements in their respective fields.

Conclusion: Carsten Schau Andersen's dedication to innovation and his groundbreaking work in the realm of enzyme variants make him a true visionary in the world of inventors. His profound impact on the industry will continue to inspire future generations of inventors to push the boundaries of what is possible and drive innovation forward.